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receptor involved in numerous pathological conditions, remains unknown. Single particle tracking 
experiments that use quantum dots specifically bound to hemagglutinin (HA)-tagged RAGE (HA-RAGE) 
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The ligand induced changes to HA-RAGE lateral diffusion do not occur when cholesterol is depleted from 
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Abstract 
The effect of ligand on the lateral diffusion of receptor for advanced glycation endproducts 
(RAGE), a receptor involved in numerous pathological conditions, remains unknown. Single 
particle tracking experiments that use quantum dots specifically bound to hemagglutinin (HA)-
tagged RAGE (HA-RAGE) are reported to elucidate the effect of ligand binding on HA-RAGE 
diffusion in GM07373 cell membranes. The ligand used in these studies is methylglyoxal 
modified-bovine serum albumin (MGO-BSA) containing advanced glycation end product 
modifications. The binding affinity between soluble RAGE and MGO-BSA increases by 1.8 to 
9.7-fold as the percent primary amine modification increases from 24 to 74% and with increasing 
negative charge on the MGO-BSA. Ligand incubation affects the HA-RAGE diffusion 
coefficient, the radius of confined domains of diffusion, and duration in confined domains of 
diffusion. There is, however, no correlation between MGO-BSA ligand binding affinity and the 
extent of the changes in HA-RAGE lateral diffusion. The ligand induced changes to HA-RAGE 
lateral diffusion do not occur when cholesterol is depleted from the cell membrane, indicating 
the mechanism for ligand-induced changes to HA-RAGE diffusion is cholesterol dependent. The 
results presented here serve as a first step in unraveling how ligand influences RAGE lateral 
diffusion.   
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1. Introduction 
The receptor for advanced glycation endproducts (RAGE) is a transmembrane receptor that is 
involved in several pathological disorders [1-3]. It is a multi-ligand pattern-recognition receptor 
with a diverse array of chemically distinct ligands [4]. Although ligand induced RAGE signaling 
has been studied extensively in various pathological states, knowledge of the molecular diffusion 
of RAGE in the cell membrane is generally unknown. The lateral diffusion of membrane 
proteins plays a role in how receptors interface with other membrane proteins, extracellular 
ligands, and intracellular proteins, and more generally, how receptors function. The goal of the 
work reported herein is to understand the effect of ligand incubation on the lateral diffusion and 
signaling of RAGE in GM07373 bovine artery endothelial cell membranes.  
RAGE consists of one variable (V) and two constant (C1 and C2) domains in the 
extracellular region, a single transmembrane domain and a short cytoplasmic tail. The RAGE 
extracellular ligand binding domains belong to the immunoglobulin superfamily. RAGE interacts 
with several ligands including advanced glycation endproducts (AGE), members of the 
S100/calgranulins family of proteins and amyloid-beta peptides [5-7]. AGE include non-
enzymatic modifications of surface amino acid residues lysine, arginine and cysteine, which may 
lead to protein cross linking. The resulting AGE-modified proteins have a net increase in 
negative surface charge [8]. Although RAGE ligands are structurally different, all ligands are 
reported to contain negatively charged regions that are important for binding. Structural analysis 
of the RAGE extracellular domain with X-ray crystallography and nuclear magnetic resonance 
spectroscopy corroborates the notion that negatively charged ligands interact with positively 
charged surfaces of the V and C1-type RAGE ectodomains [9, 10]. The binding between RAGE 
and its ligands has been measured by several techniques including surface plasmon resonance 
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(SPR) and ELISA. For example, the dissociation constants measured by SPR with human RAGE 
were 360 nM and 1.3 µM for glceraldehyde-derived and glycoladehyde-derived AGE, 
respectively [11]. A SPR analysis of the S100B-soluble RAGE interaction revealed a moderate 
affinity with an 8.3 µM dissociation constant [12]. Methylglyoxal modified-bovine serum 
albumin (MGO-BSA, a model AGE similar to the one used herein), binds to the V domain of 
RAGE with an 800 nM dissociation constant as measured by ELISA [13].  
We have recently reported properties of RAGE lateral diffusion as measured by 
fluorescence recovery photobleaching (FRAP) [14]. The lateral diffusion of RAGE and RAGE-
dependent signaling were found to be connected to the dynamics of the actin cytoskeleton. In a 
FRAP experiment, the measured diffusion parameters represent an ensemble average of 
numerous receptors. However, receptor lateral diffusion is generally not synchronized across 
each receptor, and the heterogeneity of all possible diffusion behaviors is not measured by 
FRAP. For this purpose, it is necessary to probe the diffusion one receptor at a time. One such 
approach is single particle tracking (SPT), where the receptor is exogenously labeled with a 
fluorophore and the diffusion of labeled receptor is extracted by following the trajectory of the 
label [15]. SPT has been used to study the diffusion of a variety of receptors such as G protein-
coupled receptors, epidermal growth factor receptor, and homomeric α3-containing glycine 
receptor [16-18]. For SPT, it is imperative that the signal from the fluorophore be bright and 
photostable to facilitate fast acquisition times over long durations. Inorganic quantum dots (QDs) 
satisfy the requirements, and the size of the QD can be of similar magnitude to many receptors. 
Labeling specificity to the desired receptor is achieved by modifying the QD surface with a 
ligand or another similar strategy [19]. A recent review article summarizes the use of SPT to 
measure receptor diffusion [20]. 
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Given the importance of electrostatic interactions in RAGE binding to ligand, increasing 
the negative charge of the ligand may influence binding and the functional consequences of 
binding to RAGE; this may include influencing the lateral diffusion of RAGE. To test this 
hypothesis, MGO-BSA with different extents of primary amine modification are prepared. The 
extent of modification is characterized by measuring free primary amine content and zeta 
potentials. Ligand binding between MGO-BSA and soluble RAGE (sRAGE, containing the 
RAGE extracellular domains V, C1 and C2) is measured in vitro using SPR. The effect of ligand 
on the lateral diffusion of HA-RAGE is measured with single particle tracking (SPT). The role of 
cholesterol in ligand-induced changes to HA-RAGE lateral diffusion is measured by depleting 
cellular cholesterol concentrations with methyl-β-cyclodextrin. Finally, ERK phosphorylation is 
studied in cells to identify possible correlations in HA-RAGE lateral diffusion, signaling, and 
ligand binding properties.  
 
2. Materials and Methods 
2.1. Cell culture, protein expression and Western blotting  
All microscopy and molecular biology experiments were performed using bovine artery 
GM07373 endothelial cells (Coriell Institute Biorepositories, Camden, NJ) maintained according 
to the procedure described previously [14]. GM07373 cells were transfected with purified 
recombinant plasmid using Lipofectamine 2000 and the manufacturer's instructions (Life 
Technology). Transfected GM07373 cells were selected using Geneticin sulfate (Santa Cruz 
Biotechnology, Inc., Santa Cruz, CA). The transfected cells were established to express HA-
RAGE protein stably before microscopy or molecular biology experiments. Details of the HA-
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RAGE expression plasmid, soluble RAGE expression and purification and Western blotting 
experiments are provided in the supplementary material.   
 
2.2. Preparation and characterization of methylglyoxal (MGO) modified-bovine serum albumin 
(BSA) 
BSA was modified with different concentrations of MGO to generate various MGO-BSA. 10 
mM, 40 mM, 60 mM, 80 mM and 100 mM MGO was incubated with 50 mg/mL BSA in 0.1 M 
phosphate buffered saline (PBS) pH 7.4 at 37 °C for five days. On the fifth day, unreacted MGO 
was removed by dialysis in 0.1 M PBS. The ortho-phthaldialdehyde assay was performed to 
evaluate the extent of modification via quantifying the free primary amine content of BSA [21]. 
The fluorescence intensity was measured with a microplate reader (Synergy 2 Multi-Mode 
Reader, BioTek) at excitation and emission wavelengths of 340 nm and 435 nm, respectively.  
The resulting fluorescence intensities were translated into a percent modification using the signal 
measured from unmodified BSA (without MGO incubation) as a control. 
 
2.3. Zeta potential measurement 
The zeta potential and protein mobility of the prepared MGO-BSA were obtained using a 
Zetasizer Nano ZS (Malvern Instruments, Ltd) with laser Doppler velocimetry. MGO-BSA and 
BSA control were diluted five times in PBS solution at pH=7.4. Three replicates were measured 
for each sample at 25 °C and 200 continuous runs.  
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2.4. Surface plasmon resonance (SPR) 
The binding affinity between MGO-BSA and sRAGE was measured using a home-built SPR 
instrument. The MGO-BSA was immobilized by physisorption on a 50-nm thick gold film. 100 
nM sRAGE in HEPES buffer (pH=7.5) was pumped into a flow cell at the flow rate of 0.8 
ml/min for one minute, and then the SPR response was monitored for 20 min. After the 20 min 
association step, the HEPES buffer was flowed for 1 min at the flow rate of 0.8 ml/min, and then 
the response during the dissociation step was monitored for an additional 20 min. The kinetic 
parameters for the MGO-BSA/sRAGE interaction were obtained from the resulting sensorgrams 
as previously reported using the equations provided in the supplementary material [22].  
 
2.5. Quantum dot conjugation and sample preparation for single particle tracking (SPT) 
Quantum dots (QDs, ThermoFisher Scientific) conjugated with streptavidin with an 
approximate diameter of 15 to 20 nm were used as a fluorescent probe in SPT experiments. 5 µL 
of streptavidin coated QDs in 1 µM borate buffer were added to 21 µL of monoclonal HA-
epitope tag antibody conjugated with biotin (ThermoFisher Scientific) in 74 µL of PBS buffer 
(pH=7.4) and incubated for 2 hours at room temperature. The resulting anti-HA labeled QDs 
(AHA-QDs) were stored in the refrigerator until use.  
Cells were sub cultured onto 8-well Nunc™ Lab-Tek™ chambered glass slide for 24 
hours. On the next day, spread cells were incubated with 3% (W/V) BSA in DMEM (BSA-
DMEM) medium overnight before imaging experiments to minimize the nonspecific binding.  
Cells were either used without further treatment or treated with specific MGO-BSA (5 mg/mL in 
BSA-DMEM) for 1 h. In the case of sequential cholesterol depletion, cells were further treated 
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with MβCD (5 mM in BSA-DMEM) before labeling with AHA-QDs. For SPT experiments, 
AHA-QDs were sonicated for 2 h to avoid aggregation of the QDs. The AHA-QDs were diluted 
to 100 pM in the imaging medium containing 0.1% (W/V) BSA. The low AHA-QD 
concentration reduces the possibility that two or more QDs are colocalized within the diffraction 
volume. Cells were incubated with the AHA-QDs for 15 minutes at 37 ºC in the incubator. Cells 
were then rinsed with imaging medium five times before mounting the sample onto the 
microscope.  
The SPT experiments were performed using a Nikon Eclipse TE2000U microscope 
(Melville, NY, USA) operating in wide-field, epi-fluorescence mode with a 100× objective and 
mercury lamp illumination. Filter sets for excitation (425/45 nm) and emission (605/20 nm) were 
obtained from Omega Optical (XF304-1, Brattleboro, VT, USA). The microscope was housed 
inside a physiological chamber. All imaging experiments were performed at 36 ± 2 ºC.  
Fluorescence images were collected using a PhotonMAX 512 EMCCD camera (Princeton 
Instrument, Trenton, NJ, USA) with a 40 ms camera exposure time and a full-chip (512×512 
pixels) field of view for a total of 40 s.   
 
2.6. QD binding specificity, localization, and tracking 
The AHA-QD binding specificity was measured using two cell lines: GM07373 cells that 
do not express HA-RAGE and GM07373 cells that express HA-RAGE. Nonspecific binding was 
reported as the average number of AHA-QDs in cells lacking HA-RAGE divided by the average 
number in cells expressing HA-RAGE. The ImageJ particle tracker 2D/3D plug-in implementing 
the algorithm developed by Sbalzarini and Koumoutsakos was used for detecting QDs, 
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localization, and tracking [23, 24]. The intrinsic blinking property of the QDs was used to 
identify single particles and the extracted single particle trajectories that were at least 8 s in 
duration (i.e., in between blinking events) were further analyzed.  
 
2.7. SPT data analysis 
Extracted single particle trajectories were analyzed using APM_GUI (Analyzing Particle 
Movement with Graphical User Interface), which is a MATLAB-implemented application based 
on an established algorithm reported by Simson and co-workers [25, 26]. Diffusion coefficients 
measured for AHA-QDs on GM07373 cells were used as a threshold to select mobile trajectories 
to account for the non-specific binding. All mobile trajectories were classified either as confined 
or as non-confined (Brownian) trajectories based on the probability of particle motion being 
Brownian in a given region. The probability level or the confinement index (L) was calculated 
for each trajectory to highlight the regions of confined behavior as described previously [26]. 
The simulated Brownian trajectories for a range of diffusion coefficients were used to estimate 
the critical confinement index (Lc) and critical confinement time (tc). These two parameters were 
used as a threshold to separate Brownian motion from confined motion. In general, the greater 
the value of L, the greater the tendency for a trajectory to exhibit confined motion. For a given 
trajectory, a confined diffusion region is defined by the regions where L increases above Lc for a 
duration of time longer than tc. Based on the simulation data for Brownian trajectories, the 
trajectories with L > 3.16 for a duration tc > 1.95 s had a 99.93 % likelihood to be in confined 
motion. For a trajectory classified as confined, the size of the confinement region, the duration of 
the confinement time, and the diffusion coefficients inside the confined zones and outside the 
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confined regions were further analyzed. The plot of mean square displacement (MSD) vs time 
was used to calculate the characteristic diffusion coefficient of a given region [25]. RAGE is 
reported to oligomerize on the cell surface in the presence of ligand [27-29]. It is not possible to 
know if a tracked receptor is a monomer or part of an oligomer based on its diffusion coefficient. 
This is because the diffusion coefficient has a logarithmic dependence on inverse radius, and is 
thus not particularly sensitive to clustering.   
 
3. Results and Discussion 
3.1. Characterization of MGO-BSA ligand and its interactions with RAGE  
Five MGO-BSA samples were prepared by incubating BSA with 10 to 100 mM MGO. Two of 
the possible amino acid modifications that occur after MGO incubation are shown in Figure S1. 
The extent of primary amine modification as measured by the ortho-phthaldialdehyde assay 
increases linearly (R2 = 0.98) when increasing concentrations of MGO are used for the in vitro 
modification of BSA (Figure 1A). The percent primary amine modification ranges from 24 to 
74% compared to control BSA that is not incubated with MGO. BSA that has not been incubated 
with MGO has a net positive surface charge, but all MGO-BSA samples have a net negative 
surface charge that increases as the MGO concentration used for the modification of BSA 
increases (Figure 1B).  
 RAGE ligands mainly bind to the extracellular V and C1 domains [9, 10], so a soluble 
variant for RAGE (sRAGE) is commonly used as an antigen for binding affinity studies. Surface 
plasmon resonance measurements of the dissociation constant (Kd) between each MGO-BSA 
sample and sRAGE are shown in Figure S2. The Kd values obtained from the SPR curves are 
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shown in Figure 1C. With increasing percent primary amine modification, the affinity of MGO-
BSA for sRAGE increases (i.e., the solution concentration of MGO-BSA required to occupy half 
of the available binding sites on sRAGE decreases). These affinities are of the same order of 
mangnitude as previously reported for similar RAGE ligands [13]. Combining the results of the 
affinity and MGO-BSA surface charge measurements, the affinity between sRAGE and MGO-
BSA is linearly dependent (R2 = 0.94) on the net MGO-BSA negative surface charge, which is 
consistent with an interaction to a positively charged binding pocket on the V-domain of 
sRAGE.  
14 
 
 
Figure 1. Characterization of methylglyoxal modified-bovine serum albumin (MGO-BSA). (A) 
Percent modification of free primary amines in BSA as measured by an ortho-phthaldialdehyde 
assay after modification with the indicated concentration of MGO; (B) Measured Zeta potential 
for MGO-BSA with the indicated percent primary amine modification; (C) Dissociation constant 
as measured by SPR for MGO-BSA with the indicated percent primary amine modification and 
sRAGE. 
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3.2. Extracellular HA epitope tag enables the specific labeling of QDs to RAGE  
Single particle tracking experiments require the specific binding between a nanoparticle and a 
receptor. In these studies the nanoparticles are fluorescent quantum dots (QDs). A ligand can be 
directly coated on the surface of the QDs [30, 31], however, up to 88% nonspecific binding is 
observed when ligand (AGE or S100A8/A9)-coated QDs are incubated with cells that do not 
express RAGE (data not shown). A possible reason for the observed nonspecific binding may be 
due to the affinity of RAGE ligands for other membrane proteins [8]. As an alternative specific 
labeling route, the 9 amino acid (YPYDVPDYA) hemagglutinin (HA) tag was added to the 
RAGE extracellular domain at a position three amino acids away from the N-terminus of the 
signal peptide. The cellular signaling in HA-RAGE is similar to RAGE lacking the HA tag as 
measured by phosphorylation of ERK (p-ERK). There is a two-fold increase in p-ERK in 
GM07373 cells expressing HA-RAGE compared to GM07373 cells that do not express 
detectable amounts of RAGE (Figure S3). This increase is consistent with the two-fold increase 
in p-ERK in GM07373 cells expressing RAGE lacking the HA tag, as reported previously [14]. 
In addition, a control experiment showed no change in p-ERK when HA-RAGE expressing cells 
were first exposed to HA antibody, to check for a blocked ligand binding site, followed by 
incubation with MGO-BSA with 41% primary amine modification (Figure S4). 
 Anti-HA-coated QDs (AHA-QDs) are generated by incubating streptavidin-coated QDs 
with biotin-labeled anti-HA to specifically label HA-RAGE. The specific binding of AHA-QDs 
for HA-RAGE is measured using cells that are incubated with 100 pM AHA-QDs as shown in 
Figure S5. The number of AHA-QDs per cell is counted for at least 34 cells expressing HA-
RAGE or lacking HA-RAGE. There is 4.8% nonspecific AHA-QD binding, indicating that a 
majority of the AHA-QDs observed in the HA-RAGE expressing cells are specifically bound to 
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HA-RAGE. A goal of this work is to measure the diffusion properties of HA-RAGE as measured 
by the trajectories of AHA-QDs. The nonspecifically bound AHA-QDs on the cell membrane are 
immobile and do not diffuse. To prevent biasing the HA-RAGE diffusion measurements, the 
immobile AHA-QDs are excluded from the analysis since immobile trajectories could arise from 
either nonspecific binding or immobile HA-RAGE. Excluding the immobile AHA-QDs from the 
analysis does prohibit measuring the fraction of immobile HA-RAGE.  
 
3.3. Diffusion properties for the Brownian trajectories of HA-RAGE in the presence and absence 
of MGO-BSA ligand 
Fluorescence microscopy is used to collect at least 400 trajectories of AHA-QDs from at least 10 
cells to measure the diffusion of HA-RAGE in the presence or absence of MGO-BSA. 
Trajectories are classified as exhibiting either Brownian or confined diffusion. If the trajectory 
has a minimum of one confined domain (where the confinement index (L) is higher than the 
critical confinement value for longer than the critical time as described in the experimental 
section) then the trajectory is classified as confined. In the absence of ligand, 31% of HA-RAGE 
exhibit Brownian diffusion and 69% exhibit confined diffusion, indicating a majority of HA-
RAGE measured by SPT exhibit confined diffusion at least once in ~20 seconds (i.e., the average 
length of a trajectory as shown in Table 1). When the cells are incubated with MGO-BSA, a 3 to 
7% increase in the Brownian population is measured when the MGO-BSA percent primary 
amine modification is at least 41%.   
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Table 1. Average diffusion parameters for the Brownian trajectories of HA-RAGE in the 
GM07373 cell membrane treated with MGO-BSA with the indicated percent primary amine 
modification.  
 
% of Brownian 
trajectories 
D (µm2/s) Average length of the trajectory 
(s) 
No treatment 31% 0.085 20 ± 10 
24% MGO-BSA 
treatment 
31% 0.039 
(p < 0.01) 
19 ± 9 
41% MGO-BSA 
treatment 
36% 0.052 
(p < 0.01) 
19 ± 9 
57% MGO-BSA 
treatment 
34% 0.069 
(p < 0.01) 
20 ± 10 
62% MGO-BSA 
treatment 
39% 0.115 
(p < 0.01) 
20 ± 9 
74% MGO-BSA 
treatment 
36% 0.050 
(p < 0.01) 
30 ± 10 
Diffusion coefficients with a p-value below 0.05 are highlighted in bold to show statistically 
significant differences compared to the cells that were not treated. The percentage of Brownian 
trajectories is obtained from counting, so no uncertainty is provided. 
 
 The average diffusion coefficient for the Brownian trajectories of HA-RAGE in the 
absence of ligand is 0.085 µm2/s. The histogram of diffusion coefficients (Figure 2) shows a 
bimodal population with maximum diffusion coefficients of 0.0006 and 0.065 µm2/s. When the 
cells are exposed to 24% MGO-BSA, the average diffusion coefficient drops to 0.039 µm2/s 
(Table 1). The distribution of diffusion coefficients remains bimodal but with a higher 
percentage of the slower population (Figure 2). Between 24% MGO-BSA and 62% MGO-BSA 
treatment, there is an increase in the average diffusion coefficient and a decrease in the 
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population of HA-RAGE in the slower diffusion coefficient range. Interestingly, compared to the 
62% MGO-BSA treatments, the average diffusion coefficient decreases after 74% MGO-BSA 
treatment, and there is a recurrence of the bimodal diffusion coefficient distribution. With 
increasing percent primary amine modification, the viscosity of the ligand solution increases, 
which is indicative of protein cross linking. It is possible that the decrease in the diffusion 
coefficient in going from the 62% to the 74% MGO-BSA sample is a result of extensive protein 
cross linking. The in vitro sRAGE binding studies (i.e., the SPR studies) may be less sensitive to 
the degree of protein cross linking, possibly because the sRAGE is immobilized in a range of 
orientations on the sensor surface that may have different binding capacities, while RAGE in the 
membrane is expected to have fewer degrees of freedom. Thus the affinity measured by SPR 
may not be representative of the binding affinity of full length RAGE in the cell membrane if 
extensive protein cross linking is present. It is also possible that ligand binding to another 
receptor (as stated above AGE binds to other receptors) may indirectly impact RAGE diffusion.  
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Figure 2. Histograms of diffusion coefficients for the Brownian trajectories of HA-RAGE in 
the GM07373 cell membrane treated with MGO-BSA having the indicated percent primary 
amine modification. The diffusion coefficient is plotted as the negative natural logarithm; slower 
diffusion coefficients appear on the right side of the graph. The dotted line is shown for clarity in 
comparing the changes in the distribution. 
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3.4. Diffusion properties for the fraction of HA-RAGE with at least one confined domain in the 
presence and absence of MGO-BSA ligand 
Two regions are identified for each trajectory classified as exhibiting a confined domain based 
on the measured confinement index (L). First, regions inside the confined regions where L is 
higher than the critical confinement value for longer than the critical time. Second, since the time 
HA-RAGE is in confined domains (Table 2) is less than the average trajectory time, parts of the 
trajectory represent diffusion outside confined domains.  
Table 2. Average diffusion parameters for the confined trajectories of HA-RAGE in the 
GM07373 cell membrane treated with MGO-BSA with the indicated percent primary amine 
modification.  
 
D (µm2/s) 
(Outside 
confined 
domains) 
D (µm2/s) 
(Inside 
confined 
domains) 
Radius 
(µm) 
Confinement 
time (s) 
Average 
length of the 
trajectory (s) 
No treatment 0.060 0.012 0.199 3.89 32 ± 9 
24% MGO-BSA 
treatment 
0.031 
(p < 0.01) 
0.007 
(p < 0.01) 
0.138 
(p < 0.01) 
4.09 
(p < 0.01) 
31 ± 9 
41% MGO-BSA 
treatment 
0.050 
(p < 0.01) 
0.013 
(p=0.09) 
0.192 
(p < 0.01) 
3.90 
(p=0.07) 
30 ± 10 
57% MGO-BSA 
treatment 
0.053 
(p < 0.01) 
0.011 
(p=0.09) 
0.195 
(p=0.06) 
3.99 
(p=0.2) 
30 ± 10 
62% MGO-BSA 
treatment 
0.085 
(p < 0.01) 
0.026 
(p < 0.01) 
0.294 
(p < 0.01) 
3.46 
(p=0.19) 
31 ± 9 
74% MGO-BSA 
treatment 
0.042 
(p < 0.01) 
0.010 
(p=0.01) 
0.178 
(p=0.02) 
3.97 
(p < 0.01) 
20 ± 10 
Entries with a p-value below 0.05 are highlighted in bold to show statistically significant 
differences compared to the cells that were not treated.   
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Outside of the confined domains, Brownian diffusion properties are expected. Table 2 
and Figure 3 confirm that the diffusion coefficients measured outside the confined domains of 
diffusion are within expected experimental uncertainties to the values measured for the 
trajectories exhibiting pure Brownian diffusion shown in Table 1 and Figure 2, including a 
maximum average diffusion coefficient (0.085 µm2/s) measured after treatment with 62% MGO-
BSA. When HA-RAGE is in a confined domain and in the absence of ligand, the average 
diffusion coefficient is 7-fold slower compared to HA-RAGE exhibiting Brownian diffusion. For 
HA-RAGE in confined domains in the presence of MGO-BSA, the same trends are measured in 
the average diffusion coefficient and the histogram of diffusion coefficients as measured for HA-
RAGE exhibiting Brownian diffusion, although the magnitude of the average diffusion 
coefficient is 4 to 6-fold slower within the confined domains (Table 2 and Figure 4). 
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Figure 3. Histograms of diffusion coefficients for the confined trajectories (outside domains of 
confined diffusion) of HA-RAGE in the GM07373 cell membrane treated with MGO-BSA 
having the indicated percent primary amine modification. The diffusion coefficient is plotted as 
the negative natural logarithm. The dotted line is shown for clarity in comparing the changes in 
the distribution. 
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Figure 4. Histograms of diffusion coefficients for the confined trajectories (inside domains of 
confined diffusion) of HA-RAGE in GM07373 cell membrane treated with MGO-BSA having 
the indicated percent primary amine modification. The diffusion coefficient is plotted as the 
negative natural logarithm. The dotted line is shown for clarity in comparing the changes in the 
distribution. 
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 The average confinement radius and time in confined domains measured for HA-RAGE 
in the absence of ligand were 0.199 µm and 3.89 seconds, respectively (Table 2). The 
confinement radius decreases after treatment with 24% MGO-BSA, and the confinement radius 
is the largest after 62% MGO-BSA treatment (Figure 5, Table 2).  
 
Figure 5. Distribution of confinement radius for the confined trajectories (inside domains of 
confined diffusion) of HA-RAGE in the GM07373 cell membrane treated with MGO-BSA 
having the indicated percent primary amine modification. The corresponding fits (red solid line) 
are obtained by fitting the distribution to a log-normal function. 
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Overall the confinement radius shows the same trend as the average diffusion coefficient 
with increasing MGO-BSA percent primary amine modification. The time HA-RAGE remains in 
confined domains remains approximately 4 seconds after cellular incubation with MGO-BSA. 
While the size of the domains of confined diffusion varies with MGO-BSA incubation, the time 
HA-RAGE spends within these domains is relatively independent of ligand incubation. 
 
3.5. p-ERK and HA-RAGE expression are independent of the percent primary amine 
modification on MGO-BSA 
Phosphorylation of ERK (p-ERK) and Akt (p-Akt) have been used to measure RAGE signaling 
[14, 29]. After incubation with MGO-BSA, there is a 2 to 2.4-fold increase in p-ERK compared 
to p-ERK measured in the absence of MGO-BSA (Figure 6A and 6B). There is no statistically 
significant difference in p-ERK phosphorylation for cells incubated with varying MGO-BSA 
percent primary amine modifications. A similar trend was measured for cells lacking HA-RAGE 
expression (Figure S3). Given the similar response in cells that express HA-RAGE and cells 
lacking HA-RAGE expression, it is possible that a non-RAGE-dependent mechanism is 
responsible for some or all of the increase in p-ERK  after incubation with MGO-BSA. While it 
cannot be concluded that MGO-BSA incubation results in a RAGE-dependent increase in p-
ERK, the experimental design ensures the changes in the diffusion properties discussed above 
are specific to RAGE, whether or not they are the result of a direct interaction between MGO-
BSA and RAGE or an indirect interaction with other membrane components. In contrast to the 
increasing p-ERK phosphorylation after MGO-BSA incubation, no statistically significant 
difference in p-Akt is measured is cells expressing or lacking HA-RAGE (Figure S6).    
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Figure 6. Western blot analysis of phosphorylation of ERK (p-ERK) and HA-RAGE expression 
in the GM07373 cell lysate with: (Lane 1) no treatment, or 5 mg/mL MGO-BSA treatment with 
the following percent primary amine modification: (Lane 2) 24%, (Lane 3) 41%, (Lane 4) 57%, 
(Lane 5) 62%, or (Lane 6) 74%. Fluorescence images of the PVDF membrane probed with: (A) 
p-ERK antibody or vinculin antibody, and (C) RAGE antibody or vinculin antibody. Average (n 
= 5) fluorescence intensities of the: (B) 42 kDa band of p-ERK divided by the vinculin band and 
(D) RAGE band divided by the vinculin band. 
 
There is a 15 to 28% decrease in HA-RAGE expression after incubating cells with MGO-
BSA (Figure 6C and 6D). As with p-ERK, the reduced HA-RAGE expression is statistically the 
same regardless of the percent primary amine modification on MGO-BSA. Previously, RAGE 
expression was shown to be down regulated in monocytes upon incubation with AGE prepared 
by glyceraldehyde modification [32]. The glyceraldehyde-prepared AGE reported in this 
previous study best matches the AGE used in the studies reported herein. In some experimental 
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conditions, RAGE expression has been shown to be upregulated by incubation with ligand [33, 
34].  
 
3.6. Insight into the nature of the confined domains of diffusion: Cholesterol depletion eliminates 
the ligand-induced changes to HA-RAGE diffusion 
Previously RAGE has been reported to be part of cholesterol rich membrane domains [35, 36]. 
However, cholesterol depletion did not affect the lateral diffusion properties of RAGE as 
observed with FRAP [14]. As measured by SPT, HA-RAGE diffusion is 2 to 4× slower for 
Brownian and confined diffusion when cholesterol is extracted from the cell membrane (Table 3, 
4). In addition the radius of confined diffusion decreases from 0.199 m to 0.160 m after 
cholesterol extraction. These changes are similar to the changes measured after 24% MGO-BSA 
incubation (Table 1, 2). 
 The effect of cholesterol depletion on ligand-induced changes in HA-RAGE lateral 
diffusion is explored by depleting cholesterol from untreated and 62% MGO-BSA-treated cells. 
Considering all diffusion properties for Brownian and confined diffusion, the changes in HA-
RAGE diffusion that are measured after 62% MGO-BSA treatment are not measured when 
cholesterol is extracted from the membrane (Table 3, 4 and Figure S7, S8, S9 and S10). After 
treatment with 62% MGO-BSA and cholesterol extraction, the HA-RAGE diffusion parameters 
are similar to the values measured after cholesterol extraction without ligand incubation. The 
62% MGO-BSA-induced changes in HA-RAGE diffusion are cholesterol dependent, and are not 
measured when cholesterol concentrations and/or cholesterol-dependent structures in the 
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membrane are altered. It is possible that the effect of cholesterol depletion on RAGE diffusion is 
dependent upon the level of primary amine modifications, and is worthy of further study. 
 
 
Table 3. Average diffusion parameters for the Brownian trajectories for HA-RAGE in the 
GM07373 cell membrane for the indicated cellular treatments. 
 
% of 
Brownian 
trajectories 
D (µm2/s) Average length of the 
trajectory (s) 
No treatment 31% 0.085 20 ± 10 
62% MGO-BSA ligand 36% 0.115 
(p < 0.01) 
20 ± 9 
5 mM MβCD to extract 
cholesterol  
33% 0.036 
(p < 0.01) 
19 ± 9 
62% MGO-BSA and 5mM 
MβCD  
34% 0.041 
(p < 0.01) 
18 ± 9 
Diffusion coefficients with a p-value below 0.05 are highlighted in bold to show statistically 
significant differences compared to the cells that were not treated. The percentage of Brownian 
trajectories is obtained from counting, so no uncertainty is provided. 
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Table 4. Average diffusion parameters for the confined trajectories for HA-RAGE in the 
GM07373 cell membrane for the indicated cellular treatments. 
 
D (µm2/s) 
(Outside 
confined 
domains) 
D (µm2/s) 
(Inside 
confined 
domains) 
Radius 
(µm) 
Confinement 
time (s) 
Average 
length of the 
trajectory 
(s) 
No treatment 0.06 0.012 0.199 3.89 32 ± 9 
62% MGO-
BSA ligand 
0.085 
(p < 0.01) 
0.026 
(p < 0.01) 
0.294 
(p < 0.01) 
3.46 
(p=0.19) 
31 ± 9 
5 mM MβCD 
to extract 
cholesterol  
0.035 
(p < 0.01) 
0.003 
(p < 0.01) 
0.160 
(p < 0.01) 
3.94 
(p=0.55) 
30 ± 10 
62% MGO-
BSA and 
5mM MβCD  
0.038 
(p < 0.01) 
0.008 
(p < 0.01) 
0.164 
(p < 0.01) 
3.92 
(p=0.33) 
30 ± 10 
Entries with a p-value below 0.05 are highlighted in bold to show statistically significant 
differences compared to the cells that were not treated. 
 
4. Conclusions 
MGO-BSA binding affinity to sRAGE was observed to be dependent on the percent primary 
amine modification and the net negative surface charge on the ligand. MGO-BSA incubation 
affected HA-RAGE lateral diffusion, however, there was no direct correlation measured between 
ligand binding affinity, net negative surface charge on the ligand and HA-RAGE diffusion 
coefficient, radius of confinement or duration of confinement. This may be the result of 
increasing levels of protein cross linking with increasing primary amine modification. 
Cholesterol depletion was found to ameliorate the 62% MGO-BSA ligand induced changes on 
HA-RAGE lateral diffusion, indicating a direct or indirect role for cholesterol in MGO-BSA-
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induced changes to HA-RAGE diffusion. Other factors such as ligand valancy and receptor 
clustering, as well as, other membrane changes that may result from the MGO-BSA ligand are 
possible avenues for further study.  
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